SAKAR.NS
Price:
$396
Market Cap:
$8.69B
Sakar Healthcare Limited research, develops, manufactures, and markets pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectable SVP in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in approximately 22 therapeutic areas, such as antacid, antimalerial, anticoagulant, laxative, anthelmintic, bronchodilator, anaesthetic, antidepressant, sedative, adrenergic, anti-infective, diuretics, oxytocic, analgesic, antiemetic, antipsychotic, antifungal, PPI, anticonvulsant, anti-inflammatory, antihistamine, and multi vitamins. The com...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-03-16
Stock Exchange
NSE
Ticker
SAKAR.NS
According to Sakar Healthcare Limited’s latest financial reports and current stock price. The company's current PE Ratio is 44.44. This represents a change of 23.85% compared to the average of 35.88 of the last 4 quarters.
The mean historical PE Ratio of Sakar Healthcare Limited over the last ten years is 21.99. The current 44.44 PE Ratio has changed 20.11% with respect to the historical average. Over the past ten years (40 quarters), SAKAR.NS's PE Ratio was at its highest in in the December 2021 quarter at 203.21. The PE Ratio was at its lowest in in the June 2016 quarter at 0.
Average
21.99
Median
19.53
Minimum
5.63
Maximum
65.68
Discovering the peaks and valleys of Sakar Healthcare Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 419.44%
Maximum Annual PE Ratio = 65.68
Minimum Annual Increase = -55.49%
Minimum Annual PE Ratio = 5.63
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 29.23 | -55.49% |
| 2024 | 65.68 | 124.66% |
| 2023 | 29.23 | 419.44% |
| 2022 | 5.63 | -33.59% |
| 2021 | 8.47 | -4.21% |
| 2020 | 8.85 | -15.46% |
| 2019 | 10.46 | -55.15% |
| 2018 | 23.33 | 26.17% |
| 2017 | 18.49 | -10.05% |
| 2016 | 20.56 | -17.20% |
The current PE Ratio of Sakar Healthcare Limited (SAKAR.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
41.38
5-year avg
27.65
10-year avg
21.99
Sakar Healthcare Limited’s PE Ratio is greater than Wanbury Limited (17.90), greater than Wanbury Limited (17.90), greater than Kopran Limited (18.51), greater than Kopran Limited (18.51), greater than Kilitch Drugs (India) Limited (19.56), greater than Ind-Swift Laboratories Limited (2.62), greater than Ind-Swift Laboratories Limited (2.62), greater than Titan Biotech Limited (35.59), greater than Kilitch Drugs (India) Limited (19.56), greater than Fermenta Biotech Ltd. (8.26),
| Company | PE Ratio | Market cap |
|---|---|---|
| 17.90 | $7.72B | |
| 17.90 | $7.65B | |
| 18.51 | $6.45B | |
| 18.51 | $6.42B | |
| 19.56 | $5.82B | |
| 2.62 | $6.66B | |
| 2.62 | $6.62B | |
| 35.59 | $7.82B | |
| 19.56 | $5.35B | |
| 8.26 | $8.66B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sakar Healthcare Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sakar Healthcare Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Sakar Healthcare Limited's PE Ratio?
How is the PE Ratio calculated for Sakar Healthcare Limited (SAKAR.NS)?
What is the highest PE Ratio for Sakar Healthcare Limited (SAKAR.NS)?
What is the 3-year average PE Ratio for Sakar Healthcare Limited (SAKAR.NS)?
What is the 5-year average PE Ratio for Sakar Healthcare Limited (SAKAR.NS)?
How does the current PE Ratio for Sakar Healthcare Limited (SAKAR.NS) compare to its historical average?